Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Longenesis is a private digital health company that provides software platforms connecting life-science companies, healthcare providers, researchers, and patients. Its core products, Longenesis.Engage and Longenesis.Curator, support patient engagement, consent management, cohort identification, metadata-based dataset discovery, and real-world evidence generation for research and post-market programs. The company positions itself as a privacy-preserving bridge between biomedical data holders and research sponsors, with deployments spanning hospitals, biobanks, patient organizations, and pharma partners. Longenesis appears to operate commercially rather than as a therapeutic drug developer, with a business model centered on healthcare research infrastructure and patient-centric digital programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Longenesis.